Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Chemical Science|October 28, 2014
Ru-Based <i>Z</i>-Selective Metathesis Catalysts with Modified Cyclometalated Carbene LigandsSarah M Bronner, Myles B Herbert, Paresma R Patel, et al.Journal of the American Chemical Society|January 12, 2010
Indolyne and aryne distortions and nucleophilic regioselectivitesPaul H-Y Cheong, Robert S Paton, Sarah M Bronner, et al.Angewandte Chemie (International Ed. in English)|February 7, 2012
An efficient computational model to predict the synthetic utility of heterocyclic arynesAdam E Goetz, Sarah M Bronner, Jordan D Cisneros, et al.Journal of the American Chemical Society|December 1, 2010
Indolyne experimental and computational studies: synthetic applications and origins of selectivities of nucleophilic additionsG-Yoon J Im, Sarah M Bronner, Adam E Goetz, et al.Bioorganic & Medicinal Chemistry Letters|November 25, 2017
Design and synthesis of a biaryl series as inhibitors for the bromodomains of CBP/P300Kwong Wah Lai, F Anthony Romero, Vickie Tsui, et al.Journal of Medicinal Chemistry|November 21, 2017
A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) InhibitorsSarah M Bronner, Jeremy Murray, F Anthony Romero, et al.Bioorganic & Medicinal Chemistry Letters|July 17, 2019
Design of a brain-penetrant CDK4/6 inhibitor for glioblastomaSarah M Bronner, Karl A Merrick, Jeremy Murray, et al.Journal of Medicinal Chemistry|September 12, 2017
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)F Anthony Romero, Jeremy Murray, Kwong Wah Lai, et al.Journal of Medicinal Chemistry|March 2, 2026
Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12CNicholas F Endres, Steven Do, Rana Mroue, et al.Pageof 2